Abstract
Soriano Maldonado Cristina1* and López de San Vicente Hernández Iranzu2 Author Affiliations 1Primary care physician, Primary Care Center of Muchamiel, San Juan de Alicante Department, Alicante, Spain 2Primary care physician, Primary Care Center of San Adrian, Bilbao, Spain Received: August 15, 2020 | Published: August 25, 2020 Corresponding author: Cristina Soriano Maldonado, Primary Care Center of Muchamiel, Calle del Mar, 0, 03110, Muchamiel (Alicante), Spain DOI: 10.26717/BJSTR.2020.29.004850
Highlights
IntroductionEruptive pseudoangiomatosis (EP) is a rare disease characterized by benign spontaneous regressing exanthema of an unknown etiology
Eruptive pseudoangiomatosis (EP) is a rare disease characterized by benign spontaneous regressing exanthema of an unknown etiology. It consists of an acute onset of small eruption of distinctive erythematous angioma-like papules that are often surrounded by a pale halo [1,2,3]
The first time that this disease was described was in 1969 by Cherry et al in children with enterovirus-enteric cytopathic human orphan (ECHO) virus infection [1] and Navarro, et al [6] described a case report with clinical evidence of EpsteinBarr virus (EBV) In 1993, as well as, Prose et al described an eruption with similar features in 3 children, but could not confirm its origin [2]
Summary
Eruptive pseudoangiomatosis (EP) is a rare disease characterized by benign spontaneous regressing exanthema of an unknown etiology. It consists of an acute onset of small eruption of distinctive erythematous angioma-like papules that are often surrounded by a pale halo [1,2,3]. Histologic findings show dilated dermal blood vessels with plump endothelial cells protruding into the lumen and mild-to moderate perivascular lymphohistiocytic infiltrates [4]. The etiology of this eruptive disease is still unknown. Treatment was started with cetirizine 10mg per day and the lesions spontaneously disappeared after approximately 3 weeks
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
